Navigation Links
Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research
Date:10/29/2008

h community."

Sigma-Aldrich licensed its MDQ technology from the Epigentek Group. The Imprint Methylated DNA Quantification Kit complements Sigma Life Science's epigenetic research portfolio, including the Imprint DNA Modification Kit and the Imprint ChIP Kit, as well as products for DNA purification, qPCR, sequencing and post-reaction clean-up.

"We are very excited by Sigma-Aldrich's decision to partner with Epigentek in the epigenetic field," said Adam Li, chief scientific officer at Epigentek. "This arrangement underscores Epigentek's position in the epigenetic arena, strengthens our strategy and portfolio, and is expected to benefit both companies' programs in developing new epigenetics technologies and products."

To learn more about the Imprint Methylated DNA Quantification Kit, and Sigma-Aldrich's epigenetics research product portfolio, visit http://www.sigma-aldrich.com/epigenetics.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at http://www.sigma-aldrich.com.

About Epigentek Group Inc.: Epigentek Group Inc. is a biotechnology company tha
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples
2. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
3. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
4. Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement
5. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
6. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
7. Sigma-Aldrich to Present at the UBS 2008 Global Life Sciences Conference on September 24, 2008
8. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
9. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
10. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
11. Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
Post Your Comments:
*Name:
*Comment:
*Email: